ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Wyngaarden Helps Make Case For Facilities Funding, Reveals Plan For New NIH Building

April 15, 1988

PR Firm Hired By American Cancer Society Also Represents “Team KOOL Green”.

January 28, 2000

NIH wins A-76 competition for extramural support services.

September 26, 2003

Weinstein Receives Award; LRFA Honors Vincent Devita.

June 23, 2000

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

DCCR Cancer Information Systems Program Renewed For Three More Years; Two Dropped, Two Added

September 1, 1978